CDK2 and hepatocellular carcinoma: A previous study confirmed that WTAP regulated the cyclin dependent kinase 2 (CDK2) mRNA stability in renal cell carcinoma (17), while Chen et al. (21) reported that WTAP promoted the progression of HCC in a m6A-dependent manner.